Above Poster Content
- Outdated biomedical Models
- Emphasis on psychological causes
- Misunderstanding of pathophysiology
- Minimisation of severity and disability
- No definitive biomarker
- Complex, multisystem presentation
- Overlap with other conditions
- Inconsistent criteria and guidance
- Limited clinician education
- Lack of specialist services
- Short consultations
- Dismissal and disbelief
- Poor continuity of care
- Limited treatment options
- Chronic underinvestment
- Focus on contested therapies
- Lack of prioritisation in research agendas
- Slow translation of biomedical research
- Outdated or harmful guidelines/criteria
- Lack of alignment with scientific evidence
- Poor Implementation
- Lack of patient input in policy decisions
- Stigma and misunderstanding
- Gender bias and discrimination
- "Not visible, not real" mentality
- Blame and moral judgment
The diagnosis and management of Myalgic Encephalomyelitis (M.E.) has been shaped by a range of systemic factors, including historical differences in case definitions, variability in clinical training, and the availability of specialist services. In particular, the condition has at times been conceptualised within parts of the medical and research literature through predominantly psychosomatic or psychologising frameworks, which has contributed to longstanding debate about its underlying nature.
Together, these factors have contributed to inconsistency in diagnosis, variation in clinical understanding, and unequal access to appropriate care and support.
Patients frequently report additional challenges relating to how their symptoms are received and understood within healthcare settings. These include experiences of not being believed, or of symptoms being attributed primarily to psychological causes, even in the presence of significant physical impairment. While experiences vary between clinicians and services, such reports highlight the importance of improving awareness, communication, and clinical understanding of M.E.
In the absence of standardised diagnostic pathways and widely available specialist services, the experience of people with M.E. can differ significantly depending on location and the knowledge of individual healthcare professionals. This section outlines key structural and cultural issues that have influenced how M.E. is recognised, diagnosed, and managed within the healthcare system.
Above Poster Content
Consequences of Systemic Failures
- Delayed Diagnosis and Care - average delay of 5+ years in many countries
- Worsening Health and Disability - Loss of function, crash-burn cycle, reduced quality of life
- Psychological Impact - Anxiety, depression, trauma from invalidation and neglect
- Socioeconomic Costs - Loss of education, employment, income and increased healthcare and welfare costs
- Loss of Trust - in healthcare, institutions and society
Systemic inaction perpetuates suffering.
The following posts summarise key systemic issues in the diagnosis and management of M.E.
Understanding Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS)
Mistreatment of ME - a Medical Scandal
Research Gaps and Underfunding
The Current Situation in Ireland re Myalgic Encephalomyelitis (ME)
